¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"high velocity signal loss"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® signal transduction ÇÑ±Û ½ÅÈ£Àü´Þ
¼³¸í   
  ¼¼Æ÷¿¡ À־ö¿ëüÀÇ ½ÅÈ£¼ö¿ë¿¡¼­ ±â´É¹ßÇö¿¡ À̸£±â±îÁöÀÇ Á¤º¸Àü´Þ. Áö¿ë¼ºÀÇ ½ºÅ×·ÎÀ̵åÈ£¸£¸óÀ̳ª ºñŸ¹Î µîÀ» Á¦¿ÜÇÏ°í ¼ö¿ë¼ºÈ£¸£¸ó, ½Å°æÈ­Çй°ÁúÀ̳ª ¼¼Æ÷Áõ½ÄÀÎÀÚ µîÀº ¼¼Æ÷¸·»ó¿¡ Æ¯ÀÌÀûÀΠ¼ö¿ëü¸¦ °®°í Á¤º¸¸¦ ¼¼Æ÷³»·Î ÀüÇÏ¿© ´Ù¾çÇÑ ¼¼Æ÷¹ÝÀÀÀ» ÀÏÀ¸Å²´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high velocity signal loss
    °í¼Ó½ÅÈ£¼Ò½Ç
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • high signal
    °­ÇѽÅÈ£, °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£°­µµ
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ°æ»ç, µÎ±Ø¼ÓµµºÎȣȭ±â¿ï±â
  • conduction velocity
    Àüµµ¼Óµµ
  • critical velocity
    ÀÓ°è¼Óµµ
  • flow velocity profile
    È帧¼ÓµµºÐÆ÷»ó, À¯¼ÓºÐÆ÷»ó
  • fluid velocity curve
    À¯¼Ó°î¼±
  • force velocity length relation
    Èû¼Óµµ±æÀ̰ü°è
  • nerve conduction velocity
    ½Å°æÀüµµ¼Óµµ
  • propagation velocity
    1. Áõ½Ä¼Óµµ 2. ÀüÆÄ¼Óµµ
  • pulse wave velocity
    ¸Æ¹ÚÆÄÀüÆÄ¼Óµµ
  • reaction velocity
    ¹ÝÀÀ¼Óµµ
  • sperm velocity
    Á¤ÀÚ¼Óµµ
  • sedimentation velocity
    ħÀü¼Óµµ, ħ°­¼Óµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • loss
    »ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • loss of short-term variability
    ´Ü±âº¯µ¿¼Ò½Ç
  • velocity
    ¼Óµµ
  • blood flow velocity
    ÇÇÈ帧¼Óµµ, Ç÷·ù¼Óµµ
  • nerve conduction velocity
    ½Å°æÀüµµ¼Óµµ
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
  • propagation velocity
    Áõ½Ä¼Óµµ, ÀüÆÄ¼Óµµ
  • reaction velocity
    ¹ÝÀÀ¼Óµµ
  • high altitude
    °íÁö-, °í¼Ò-
  • high risk group
    °íÀ§Ç豺
  • high-dose
    °í¿ë·®
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£°­µµ
  • velocity aliasing
    ¼ÓµµµÑ·¯°ãħ
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ±â¿ï±â, µÎ±Ø¼ÓµµºÎȣȭ±â¿ï±â
  • blood flow velocity
    ÇÇÈ帧¼Óµµ, Ç÷·ù¼Óµµ
  • conduction velocity
    Àüµµ¼Óµµ
  • constant velocity
    °íÁ¤¼Óµµ
  • critical velocity
    ÀÓ°è¼Óµµ
  • fluid velocity curve
    À¯¼Ó°î¼±
  • velocity constant
    ¼Óµµ»ó¼ö
  • velocity encoding
    ¼ÓµµºÎȣȭ
  • flow velocity profile
    È帧¼ÓµµºÐÆ÷»ó, À¯¼ÓºÐÆ÷»ó
  • force velocity length relation
    Èû¼Óµµ±æÀ̰ü°è
  • velocity focusing
    ¼ÓµµÁý¼Ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high velocity signal loss
    °í¼Óµµ ½ÅÈ£ ¼Ò½Ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£ °­µµ
  • angular velocity
    °¢¼Óµµ
  • pulse wave velocity
    ¸ÆÆÄÀüÆÄ¼Óµµ(Øæ÷îï³÷îáÜöô).
  • MR signal
    ÀÚ±â°ø¸í ½ÅÈ£
  • SNR (signal to noise ratio)
    ½ÅÈ£´ë ÀâÀ½ºñÀ²
  • analog signal
    ¾Æ³¯·Î±× ½ÅÈ£
  • free induction decay signal (FID)
    ÀÚÀ¯ À¯µµ ºØ±« ½ÅÈ£
  • immunogenic signal
    ¸é¿ª¿ø½ÅÈ£
  • predictive value of control signal
    Á¦¾î<´ëÁ¶>½ÅÈ£ÀÇ ¿¹ÃøÄ¡
  • primary signal system
    ÀÏÂ÷½ÅÈ£°è(ìéó­ãáûÜ Í§).
  • quadrature signal detection
    ±¸Àû ½ÅÈ£ ŽÁö
  • Heat loss
    ¿­¼Õ½Ç(æðáßã÷)
  • NIHL [=noise induced hearing loss]
    ¼ÒÀ½¼º ³­Ã»
  • abrasion loss
    ¸¶¸ê·®(¸¶¸ê¾ç).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high velocity signal loss
    °í¼Óµµ ½ÅÈ£ ¼Ò½Ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • signal loss
    ½ÅÈ£ ¼Ò½Ç
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£ °­µµ
  • analog signal
    ¾Æ³¯·Î±× ½ÅÈ£
  • backscatter signal
    ÈÄ¹æ »ê¶õ ½ÅÈ£
  • clutter signal
    È¥¶õ ½ÅÈ£
  • echo signal
    ¿¡ÄÚ ½ÅÈ£
  • flow signal
    À¯µ¿ ½ÅÈ£
  • free induction decay signal (FID)
    ÀÚÀ¯ À¯µµ ºØ±« ½ÅÈ£
  • immunogenic signal
    ¸é¿ª¿ø½ÅÈ£
  • low signal
    Àú½ÅÈ£
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • number of signal average (NSA)
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • off-resonance signal
    ÀÌÅ» °ø¸í ½ÅÈ£
  • packaging signal
    ²Ù¸®±â½ÅÈ£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coincidence loss
    µ¿½Ã¼Õ½Ç(ÔÒãÁáßã÷)
  • counting loss
    "°èÃø ¼Õ½Ç(ͪö´áßã÷), (ÔÒ) coincidence loss"
  • density gradient sedimentation velocity
    ¹Ðµµ±¸¹è ħ°­ ¼Óµµ(ÚËÓøÎþÛÕöØË½áÜÓø)
  • initial velocity
    ÃÊ(±â)¼Óµµ (ôø(Ñ¢)áÜÓø)
  • limiting velocity
    Á¦ÇѼӵµ(ð¤ùÚáÜÓø)
  • linear velocity
    ¼±¼Óµµ(àÊáÜÓø)
  • maximum velocity
    ÃÖ´ë¼Óµµ(õÌÓÞáÜÓø)
  • sedimentation velocity
    ħ°­¼Óµµ(öØË½áÜÓø)
  • velocity
    ¼Óµµ(áÜÓø)
  • velocity constant
    ¼Óµµ(áÜÓø) »ó¼ö(ßÈâ¦)
  • dual signal hypothesis
    ÀÌÁß ½ÅÈ£¼³(ì£ñìãáûÜàã) (ÔÒ) synarchy
  • signal amplification
    ½ÅÈ£ÁõÆø(ãáûÜñòøë)
  • signal codons
    ½ÅÈ£(ãáûÜ)ÄÚµ·
  • signal hypothesis
    ½ÅÈ£¼³(ãáûÜàã)
  • signal peptide
    ½ÅÈ£(ãáûÜ)ÆéŸÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£°­µµ
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã»
  • energy loss
    ¿¡³ÊÁö¼Õ½Ç
  • hearing loss
    û°¢¼Õ½Ç
  • sensorineural hearing loss
    °¨°¢½Å°æ¼º³­Ã»
  • weight loss
    üÁß°¨¼Ò, °¨·®
  • assumed velocity profile
    °¡»ó¼ÓµµºÐÆ÷»óÅÂ
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ°æ»ç
  • constant velocity
    °íÁ¤¼Óµµ
  • flow velocity profile
    À¯¼ÓºÐÆ÷»ó
  • fluid velocity curve
    À¯¼Ó°î¼±
  • time velocity integral
    ½Ã°£¼ÓµµÁ¤¼ö
  • velocity
    ¼Óµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HP halogen phosphorus; handicapped person; haptoglobin; hard palate; Harvard pump; health profession(al...
DVI deep venous insufficiency; diastolic velocity integral; digital vascular imaging; Doppler velocity i...
HF Hageman factor; haplotype frequency; hard filled [capsule]; hay fever; head of fetus; head forward; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VSL velocity , straight line velocity
Ahl Age-related hearing loss
ABL Alveolar bone loss
CLV Corrected Loss Variance
EELS Electron Energy Loss Spectroscopy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • high velocity signal loss
    °í¼Óµµ ½ÅÈ£ ¼Ò½Ç
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • signal loss
    ½ÅÈ£ ¼Ò½Ç
  • high signal intensity
    °í½ÅÈ£ °­µµ
  • assumed velocity profile
    °¡»ó ¼Óµµ ºÐÆ÷ »óÅÂ
  • blood flow velocity
    Ç÷·ù ¼Óµµ
  • minimum conduction velocity
    ÃÖ¼Ò À¯µµ ¼Óµµ
  • peak height velocity
    ½ÅÀåÀÇ ÃÖ´ë Áõ°¡, ÃÖ´ë Áõ°¡·® °î¼±
  • tissue fragmentation velocity
    Á¶Á÷ ºÐ¼â ¼Óµµ
  • velocity
    ¼Óµµ
  • analog signal
    ¾Æ³¯·Î±× ½ÅÈ£
  • backscatter signal
    ÈÄ¹æ »ê¶õ ½ÅÈ£
  • bioelectric signal
    »ý¹°ÇÐÀû Àü±âÀû ½ÅÈ£
  • bright signal
    ¹àÀº »ó
  • echo signal
    ¿¡ÄÚ½ÅÈ£
  • expressive or signal output process
    Ç¥Çö¼º, ȤÀº ½ÅÈ£ÀÇ Ãâ·ÂÈ­ °úÁ¤
  • flow signal
    À¯µ¿ ½ÅÈ£
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hearing loss, high-frequency Hearing loss in frequencies above 1000 hertz.
(12 Dec 1998)
COOH-terminal signal transamidase <enzyme> Present in the endoplasmic reticulum; catalyses concomitant cleavage of the signal peptide of nascent proteins destined to be processed to a glycosylphosphatidylinositol (gpi) and addition of the gpi anchor
Registry number: EC 2.3.2.-
Synonym: cooh-ts-transamidase, gpi transamidase, gpti transamidase
(26 Jun 1999)
signal 1. Noticeable; distinguished from what is ordinary; eminent; remarkable; memorable; as, a signal exploit; a signal service; a signal act of benevolence. "As signal now in low, dejected state As erst in highest, behold him where he lies." (Milton)
2. Of or pertaining to signals, or the use of signals in conveying information; as, a signal flag or officer. The signal service, a bureau of the government (in the United States connected with the War Department) organised to collect from the whole country simultaneous raports of local meteorological conditions, upon comparison of which at the central office, predictions concerning the weather are telegraphed to various sections, where they are made known by signals publicly displayed. Signal station, the place where a signal is displayed; specifically, an observation office of the signal service.
Synonym: Eminent, remarkable, memorable, extraordinary, notable, conspicuous.
Origin: From signal, n., cf. F. Signale.
Source: Websters Dictionary
(01 Mar 1998)
signal detection (psychology) A theory of psychophysics which characterises not only the acuity of an individual's discrimination but also the psychological factors that bias his judgment.
(12 Dec 1998)
signal node A firm supraclavicular lymph node, especially on the left side, sufficiently enlarged that it is palpable from the cutaneous surface; such a lymph node is so termed because it may be the first recognised presumptive evidence of a malignant neoplasm in one of the viscera. A signal node that is known to contain a metastasis from a malignant neoplasm is sometimes designated by an old eponym, Troisier's ganglion.
Synonym: jugular gland, Virchow's node.
(05 Mar 2000)
signal peptidase A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
signal peptidase complex A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
signal peptide A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
signal peptide p25-subunit IV cytochrome oxidase <chemical> Similar in action to melittin
Synonym: p25 presequence peptide-cytochrome oxidase, pre-ctox p25
(26 Jun 1999)
signal peptides Additional polypeptide sequence of 25 to 30 residues at the amino-terminal or carboxy-terminal end of proteins. The signal sequence signals the cellular fate or destination of a newly synthesised protein directing it to its ultimate destination in the cell. These leaders are recognised by the signal recognition particle and bound by specific receptor sites on the outer surface of the endoplasmic reticulum. They are then transported into the cisterna of the endoplasmic reticulum and from there directed to their ultimate destination in the cell. In prokaryotes, the signal peptides attach to the plasma membrane. These signal sequences are ultimately removed by specific peptidases.
(12 Dec 1998)
signal processing, computer-assisted Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.
(12 Dec 1998)
signal recognition particle A complex between a 7S RNA and six proteins. SRP binds to the nascent polypeptide chain of eukaryotic proteins with a signal sequence and halts further translation until the ribosome becomes associated with the rough endoplasmic reticulum. One of the SRP proteins (srp54) binds GTP and in association with 7SRNA and srp19 has GTPase activity.
(18 Nov 1997)
signal recognition particle receptor Receptor for the signal recognition particle (SRP) found in the membrane of the endoplasmic reticulum. Also called docking protein. Heterodimeric, both protomers having GTP binding capacity, though dissimilar binding sites. Not until the complex of SRP, ribosome, message and nascent polypeptide chain binds to the SRP receptor is the block to further chain elongation released and concurrently the SRP is released, leaving the ribosome attached to the endoplasmic reticulum membrane. Cotranslational transport of the polypeptide delivers it into the lumen of the ER.
(18 Nov 1997)
signal response coupling The cascade of processes by which an extracellular signal (typically a hormone or neurotransmitter) interacts with a receptor at the cell surface, causing a change in the level of a second messenger for example calcium or cyclic AMP) and ultimately effects a change in the cells functioning (for example: triggering glucose uptake or initiating cell division). Can also be applied to sensory signal transduction, for example of light at photoreceptors.
(18 Nov 1997)
signal sequence A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • be at a loss
    ºÒÈ®½ÇÇÑ »óÅ¿¡ ÀÖ´Ù
  • loss
    ºÐ½Ç
  • consequential loss insurance
    °£Á¢ ¼ÕÇØ º¸Çè
  • dead loss
    Àü¼Õ
  • friction loss
    ¸¶Âû¼Õ½Ç
  • loss
    ¼Õ½Ç;»ó½Ç;¼ÕÇØ;½ÇÆÐ;ÆÐ¹è;¼Ò¸ð;at a ~ °ï¶õÇÏ¿©;¾î¿ ÁÙ ¸ô¶ó¼­
  • loss leader
    Ư¸Åǰ
  • velocity
    ¼Óµµ
  • angular velocity
    °¢¼Óµµ
  • characteristic velocity
    (·ÎÄÏÀÇ)Ư¼º ¼Óµµ
  • circular velocity
    ¿ø±Ëµµ ¼Óµµ
  • earth orbital velocity
    Áö±¸ ±Ëµµ ¼Óµµ
  • escape velocity
    (·ÎÄÏÀÇ)Å»Ãâ¼Óµµ
  • group velocity
    (ÆÄµ¿ÀÇ)±º¼Óµµ
  • radial velocity
    ½Ã¼± ¼Óµµ(õü°¡ °üÃøÀÚÀÇ ½Ã¼± ¹æÇâ¿¡ °¡±î¿Í Áö°Å³ª ¸Ö¾îÁö´Â ¼Óµµ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á